| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |